Background {#Sec1}
==========

There has been an important shift toward the use and development of quality patient-reported outcome (PRO) instruments that minimize responder burden and exhibit sufficient reliability, validity, and clinical relevance. \[[@CR1]\] These tools can assist in the accurate measurement of clinical outcomes, which are fundamental for rigorous clinical research as well as in improving the quality of care offered to patients. In order for PRO instruments to have these desired research and clinical benefits, validation studies are critical. Fitting this new emphasis, the Journal of Patient-Reported Outcomes has included rigorous studies on the development and evaluation of PROs in the aims and scope of the journal. \[[@CR2]\] Determining whether a PRO instrument is responsive---i.e. able to detect a change in a patient's reported health status or function---is an important pre-requisite for using such instruments to assess treatment effect.

The Patient-Reported Outcomes Measurement Information System (PROMIS) health measure improvement initiative was funded by the National Institutes of Health with the purpose of improving the quality of PROs. The development took a systematic approach, drawing from instruments already in use. Existing items were categorized, reviewed, and revised, creating a large pool of items that were then validated with item-response theory to allow for computer adapted testing, making the PROMIS instruments an important contribution to clinical and research practice while minimizing respondent burden. \[[@CR3]--[@CR5]\] The PROMIS Physical Function Computer Adaptive Test (PF CAT) and PROMIS Upper Extremity (UE) CAT instruments can be utilized to measure patients' self-reported upper extremity health status, and have several advantages over other metrics. \[[@CR6]\] The PROMIS UE and PF CAT have both demonstrated favorable performance characteristics and correlate well with the shortened version of the Disabilities of the Arm, Shoulder, and Hand (qDASH) in an orthopaedic upper extremity patient population. \[[@CR7], [@CR8]\] The responsiveness of these PROMIS instruments have not yet been evaluated in this same patient population.

Assessing responsiveness requires longitudinal data with repeated measures, where the same individual is assessed with the same instrument on at least two occasions. \[[@CR9]\] Responsiveness can be assessed with either internal or external methods. Internal analysis of responsiveness evaluates the level of change based on the size of the differences between scores, and how much scores vary over time. \[[@CR10]\] External responsiveness methods use an external anchor to relate the level of change to some other meaningful report of patient change, either a clinical gold-standard assessment or the patient's own report of change. \[[@CR11], [@CR12]\] Detecting change is particularly important for PRO instruments if they are to be used to guide decisions in clinical practice.

The purpose of this study, therefore, is to evaluate the responsiveness of three PROMIS patient-reported outcome measures in patients with hand and upper extremity (non-shoulder) disorders and provide comparisons with the qDASH legacy instrument.

Methods {#Sec2}
=======

Patient sample {#Sec3}
--------------

Institutional Review Board approval was obtained prior to the start of this study and informed consent was obtained from all participants as they sought medical care for orthopaedic conditions. The sample consisted of 255 new patients presenting to an academic upper-extremity (non-shoulder) clinic between the years of 2014 and 2016. All patients were 18 years or older and sought treatment for upper extremity musculoskeletal conditions. At the time of their clinic visits and prior to seeing a physician, patients were administered anchor questions and PROs electronically on a handheld tablet computer. Patients were recruited consecutively and PROs were administered as part of the standard clinic treatment protocol, with 1.5% of patients refusing to participate clinic-wide.

Patients were seen for a variety of upper extremity conditions with treatments including wound and bone care, skin grafts, tendon/ligament repair, incisions, implants, bursas, reconstructions, fractures, transplants, decompression, arthroscopy, endoscopy, nerve blocks, and carpel tunnel surgery. Depending on individual patient circumstance and timing in follow-up care, different patient samples could be included in the different follow-up periods (see Table [1](#Tab1){ref-type="table"}). Also, depending on the diagnostic condition and treatment planning, patients differed in the amount or type of treatment received during the follow-up periods. This variation in treatment and follow-up timing is typical of a standard UE orthopaedic practice. Four patient follow-up periods were examined in this study: (1) 3-month follow-up (i.e., 80 to 100 days after initial assessment; (2) \>3-month follow-up (i.e., 90 days or more after initial assessment); (3) 6-month follow-up (i.e., 170 to 190 days after initial assessment); and (4) \>6-month follow-up (i.e., 180 days or more after initial assessment). Three and six-months are common time-periods for follow-up in orthopaedic practice. \[[@CR13]--[@CR20]\] These time-points were included in this analysis to correspond with prior literature and clinical practice.Table 1Demographics of patientsPatient characteristics*n*PercentMean (SD)RangeAge (years)50.75 (15.84)18--90Gender Male12448.6 Female13151.4Race White or Caucasian22186.7 Asian41.6 American Indian and Alaska Native31.2 Black or African American62.4 Other155.9 Missing62.4Ethnicity Hispanic187.1 Non-Hispanic23291.0 Missing51.9Tobacco User Yes259.8 No21182.7 Missing197.5Procedure Type Removal of implant41.6 Excision, repair, surgery on the Humerus72.8 Excision, repair, surgery on the wrist or forearm176.7 Excision, repair, surgery on the hands and fingers4316.8 Amputation procedures on the hand10.4 Neuroplasty, neurorrhaphy, arthroscopy, and misc. procedures13352.2 Missing5019.5Insurance Provider Industrial/Workers Compensation239.0 Medicaid10.4 Medicare4919.2 No Fault Auto Insurance31.2 Private Insurance16866.2 Self-Pay62.4 Tricare31.2Employment Status Disabled145.5 Full Time12147.5 Part Time135.1 Not employed2811.0 Retired3614.1 Self Employed135.1 Student93.5 Missing218.2

Patient-reported outcome measures {#Sec4}
---------------------------------

Three PROMIS instruments were administered to the patients: the PROMIS UE CATv1.2, the PROMIS PF CAT v1.2, and the PROMIS Pain Interference (PI) CAT v1.1. The PROMIS PF CAT v1.2 contains both upper extremity and lower extremity items and draws from a 121-item test bank. The PROMIS UE CAT v1.2 has a 16-item test bank and the PROMIS PI CAT v1.1 has a 40-item test bank. The qDASH was also administered, which is an 11-item, validated, shortened version of the 30-item Disabilities of the Arm and Shoulder (DASH) instrument. \[[@CR21]\] The PROMIS instruments were made available through the Assessment Center, a secure web-based portal established by PROMIS developers. \[[@CR22]\] Each of the four instruments were administered at baseline (i.e., either within seven days prior to the clinic visit of a new upper extremity condition or on the day of the first clinic visit) and at each follow-up visit patients attended.

All PROMIS instruments were calibrated in the general population with a mean of 50 and a standard deviation of 10 in the T-score scale, with patient scores primarily clustering between 20 to 80 points. \[[@CR23]\] The larger the PROMIS PF or UE scores, the higher were the patients' function, where the larger the PROMIS PI scores, the greater the pain interference experienced by the patients. The qDASH scores ranged from 0 to 100 with higher scores representing lower functioning levels.

Anchor questions {#Sec5}
----------------

For physical function, patient responses were anchored by the question; 'Compared to your FIRST EVALUATION at the University Orthopaedic Center: how would you describe your physical function now?'(much worse, worse, slightly worse, no change, slightly improved, improved, much improved). The idea of anchoring a change score to some other measure of patient outcome is to provide a reference point. When that reference point comes from patient reports of noticeable improvement or decline, it may be considered a meaningful level of change. \[[@CR24]\] Patients reporting meaningful change (much worse, worse, improved, much improved) were included in the responsiveness analysis to detect the ability of the PROs to measure meaningful levels of change. \[[@CR25]\] When there is symmetry in data characteristic, the improved and deteriorated change groups can be considered together creating a distinction between those experiencing change versus those with stable symptomology. \[[@CR26]\]

For the PI, the anchor question queried pain (i.e., Compared to your FIRST EVALUATION at the University Orthopaedic Center: how would you describe your episodes of PAIN now?) rather than physical function, and patients reporting pain which was worse, much worse, improved, or much improved since their first clinic visit were included in the responsiveness analyses.

Statistical analysis {#Sec6}
--------------------

Patient demographics were examined and changes in their functional and pain outcomes were evaluated at four time points. Baseline scores were compared to the three-month follow-up scores (90 days plus or minus 10 days), six-month follow-up scores (180 days plus or minus 10 days), 90 days and beyond follow-up scores, and 180 days and beyond follow-up scores on all four patient-reported measures.

Change in the PRO metrics was calculated as the absolute value difference between the baseline score and the follow-up score for each patient. A paired sample two sided t-test was used to test the hypothesis that there was no difference in the PRO measures between time points on an individual patient level \[[@CR10]\], with significance level set at *p* = 0.05. ANOVA was run to test the hypothesis that patients did not differ across levels of change.

A standardized measure of effect size (ES) was calculated using the Cohen's d. Cohen's d computes the difference in score between the baseline and the follow-up and then divides this difference by the baseline score standard deviation. This method takes into consideration the variability in scores, a step beyond the mean differences considered in the paired sample t-test \[[@CR10]\]. In interpreting Cohen's d, a small, medium, and large ES can be considered as d = 0.20, 0.50, and 0.80 respectively.

The standardized response mean (SRM) is another important indicator of ES, similar to the paired t-test, but removing dependence on sample size from the equation. \[[@CR10]\] This is computed as the mean difference between baseline and follow-up PRO scores divided by the standard deviation of difference scores, reflecting individual changes in scores. Although there is not perfect consensus, recommended guidelines for interpreting SRM values are similar to interpretation of Cohen's d. \[[@CR10]\] All analyses were performed using either SPSS 23.0 (IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp.), \[[@CR27]\] or R 3.30 (R Development Core Team, Vienna, AT: R Foundation for Statistical Computing,) \[[@CR28]\].

Results {#Sec7}
=======

This study included a total of 131 females and 124 males with ages ranging from 18 years to 90 years (mean age = 50.75, SD = 15.84). For demographic information including gender, race, ethnicity, tobacco use, procedure and insurance type, see Table [1](#Tab1){ref-type="table"}.

Mean, SD, range, and median along with mean differences of scores of the PROMIS UE, PF, PI and qDASH are presented in Table [2](#Tab2){ref-type="table"}. Mean change scores for the PROMIS PI ranged from 4.81--10.68 whereas mean for no change scores ranged from 4.32--6.05. The PROMIS PI at 3-month and \>3-month follow-up and the qDASH at \>3-month follow-up were the only measures and only time-points with confidence intervals (CI)'s showing a substantial difference between change groups (see Table [3](#Tab3){ref-type="table"}). The PROMIS PF mean change scores ranged from 8.36--8.91 whereas mean for no change scores ranged from 5.92--9.00. The UE had mean change scores ranging from 7.57--9.51 and mean no change scores ranging from 6.67--8.21. Lastly, the qDASH showed mean change scores between 18.18 and 24.22 and mean no change scores between 17.21 and 24.40.Table 2Descriptive statistics of PROMIS instruments and qDASH of patientsInstrument*n*Mean (SD)RangeMedianBaseline PROMIS PF25445.45 (9.53)23.47--70.2543.18 PROMIS PI25460.85 (7.34)38.67--80.9661.52 PROMIS UE25432.48 (9.28)14.66--56.3932.13 qDASH25550.09 (22.53)4.54--97.7350.003-month follow-up PROMIS PF3150.61 (10.73)33.10--50.6151.45 PROMIS PI3152.77 (8.62)38.67--71.6052.57 PROMIS UE2836.89 (10.14)18.34--56.3936.53 qDASH2933.39 (23.74)2.27--79.5427.27\>3-month follow-up PROMIS PF15146.34 (8.76)24.07--73.2847.41 PROMIS PI17756.20 (8.47)38.67--80.0755.98 PROMIS UE14834.95 (8.30)18.34--56.3935.09 qDASH14939.73 (22.76)2.27--97.7236.366-month follow-up PROMIS PF1847.70 (5.59)32.60--56.0647.83 PROMIS PI2055.94 (3.46)50.12--62.6455.10 PROMIS UE1835.62 (8.13)18.35--56.2635.85 qDASH1834.84 (16.16)11.36--77.2735.23\>6-month follow-up PROMIS PF5344.51 (10.23)2.84--70.2544.72 PROMIS PI6256.77 (8.87)38.67--79.9955.98 PROMIS UE5233.77 (8.66)17.74--56.3934.54 qDASH5541.79 (25.67)6.82--93.1836.36 Table 3Mean Score Changes for PROMIS Instruments and qDASHInstrument*n*No Change (SD)*n*Change (SD)Mean Difference \[95% CI\]^a^3-month follow-up PROMIS PF299.00 (8.18)318.64 (8.20)0.36 \[−3.88, 4.59\] PROMIS PI255.95 (7.51)3110.68 (6.56)−1.47 \[−8.50, −0.96\] PROMIS UE288.04 (6.19)289.51 (7.54)0.18 \[−5.17, 2.24\] qDASH3024.40 (20.53)2924.22 (16.81)−4.72 \[−9.62, 9.98\]\>3-month follow-up PROMIS PF1777.14 (6.85)1518.53 (7.31)−1.39 \[−2.93, 0.15\] PROMIS PI1456.05 (5.78)1777.48 (6.86)−1.44 \[−2.82, −0.05\] PROMIS UE1737.44 (6.46)1488.54 (6.86)−1.10 \[−2.56, 0.36\] qDASH17518.23 (17.10)14922.34 (17.75)−4.10 \[−7.93, −0.27\]6-month follow-up PROMIS PF115.92 (6.23)188.91 (7.06)−2.99 \[−8.30, 2.33\] PROMIS PI94.32 (3.70)204.81 (4.16)−0.48 \[−3.80, 2.83\] PROMIS UE118.21 (5.46)187.57 (5.33)0.64 \[−3.58, 4.87\] qDASH1117.77 (14.40)1818.18 (13.34)−0.41 \[−11.60, 10.77\]\>6-month follow-up PROMIS PF786.73 (5.65)538.36 (6.67)−1.62 \[−3.78, 0.53\] PROMIS PI695.97 (5.35)626.71 (5.85)−0.74 \[−2.69, 1.20\] PROMIS UE766.67 (6.50)528.37 (5.84)−1.70 \[−3.92, 0.52\] qDASH8117.21 (17.09)5521.86 (17.34)−4.65 \[−10.60, 1.29\]^a^This is the mean difference with its associated 95% confidence interval between the no change score and the change score

Only 20% of the patient sample had baseline PROMIS PF scores at the average 50th percentile T-score of 50, 5% had PROMIS UE scores over 50, and 5% had an average PROMIS PI pain score of 50, indicating this group had low levels of function and high levels of pain at baseline.

Paired t-test {#Sec8}
-------------

At the 3-month, 6-month and \>3-month follow-up, changes from baseline scores were significant for all instruments (*p* \< 0.05). However, score changes for the \>6-month time period varied in significance. The only instrument that did not show a significant change in scores was the UE CAT (*p* = 0.253), whereas the PF CAT, PI CAT, and qDASH showed significant changes in scores (*p* \< 0.05; see Table [4](#Tab4){ref-type="table"}). For all instruments, the baseline scores were not significantly different between the patients with missing and non-missing follow-up visit scores at all time points (*p* \< 0.05) (results available upon request).Table 4Responsiveness of PROMIS instruments and qDASH of patients from baselineFollow-up PeriodInstrument*n*SRM \[95% CI\]ES \[95% CI\] *p*-valuePaired t-test3-month follow-upPROMIS PF311.05 \[0.51, 1.57\]0.84 \[0.31, 1.35\]\< 0.001PROMIS PI311.63 \[1.04, 2.18\]1.48 \[0.90, 2.02\]\< 0.001PROMIS UE281.26 \[0.67, 1.81\]1.05 \[0.48, 1.59\]0.006qDASH291.44 \[0.84, 2.00\]1.12 \[0.28, 1.66\]\< 0.001\>3-month follow-upPROMIS PF1501.16 \[0.91, 1.40\]0.92 \[0.68, 1.16\]\< 0.001PROMIS PI1761.09 \[0.86, 1.31\]0.99 \[0.77, 1.21\]\< 0.001PROMIS UE1481.24 \[0.99, 1.49\]0.88 \[0.64, 1.12\]0.001qDASH1491.26 \[1.01, 1.51\]0.97 \[0.73, 1.21\]\< 0.0016-month follow-upPROMIS PF181.26 \[0.52, 1.94\]0.83 \[0.13, 1.49\]\< 0.001PROMIS PI201.16 \[0.47, 1.80\]0.79 \[0.13, 1.42\]\< 0.001PROMIS UE181.42 \[0.66, 2.12\]0.85 \[0.15, 1.51\]0.001qDASH181.36 \[0.61, 2.05\]0.80 \[0.10, 1.46\]\< 0.001\>6-month follow-upPROMIS PF521.25 \[0.82, 1.66\]0.87 \[0.46, 1.27\]0.033PROMIS PI611.15 \[0.76, 1.53\]0.96 \[0.58, 1.33\]\< 0.001PROMIS UE521.43 \[0.99, 1.85\]0.85 \[0.44, 1.24\]0.253qDASH551.26 \[0.84, 1.66\]0.93 \[0.53, 1.32\]0.006

Effect size {#Sec9}
-----------

All four instruments showed a high degree of responsiveness across all four follow-up periods. For the 3-month follow-up group, all instruments had high responsiveness ranging from 0.84--1.48. The instrument that was the most responsive for the 3-month follow-up was the PI CAT (1.48), whereas the PF CAT was the least responsive (0.84).

The 6-month follow-up also showed high responsiveness ranging from 0.79--0.85. The PI CAT was the least responsive at the 6-month follow-up (0.79) whereas the UE CAT was the most responsive (0.85). When looking at the \>3-month follow-up time period of 90 days or more, responsiveness was still high (0.92--0.99). The least responsive measurement for this time period was the UE CAT (0.92) while the PI CAT showed the highest responsiveness (0.99). For the \>6-month time period of 180 days or more, all instruments still showed high responsiveness but the PI CAT was the most responsive (0.97) whereas the UE CAT was the least (0.85). Overall, the PI CAT was consistently the most responsive to change when looking at ES (see Table [4](#Tab4){ref-type="table"}). The 95% CI's of the effect sizes demonstrates a meaningful difference in measure responsiveness at each follow-up time-point for each instrument, though the CI range for all measures dipped to include potential for a small effect in the 6-month follow-up period.

Standardized response mean {#Sec10}
--------------------------

All instruments had high responsiveness as measured by the SRM (1.05--1.63). The 95% CI's around the SRM were all medium-large, ranging from 0.51--2.18, and reflect the overall larger size of effect as measured by the SRM compared to the ES on every measure at every time-point. In the 3-month follow-up group, the most responsive instrument was the PI CAT (1.63) while the PF CAT was the least responsive instrument (1.05) among the four. The 6-month follow-up showed that the PROMIS UE was the most responsive (1.42) whereas the PI CAT was the least (1.16). In the \>3-month follow-up time period of 90 days or more, the PI CAT remained the least responsive instrument (1.09) whereas the qDASH was the most responsive (1.26). However, the UE CAT had the highest SRM (1.43) while the PI CAT had the lowest (1.15) for the \>6-month follow up time period of 180 days or more. In general, the UE CAT was the most responsive to change when applying the SRM (see Table [4](#Tab4){ref-type="table"}).

Discussion {#Sec11}
==========

The main finding of this study is that the PROMIS Upper Extremity CAT, Physical Function CAT, and Pain Interference CAT are responsive to patient reported functional change in a hand and upper extremity (non-shoulder) orthopaedic population. In addition, the magnitude of the responsiveness for each instrument was large. The three statistical methods (SRM, ES, and paired t-test) that were utilized provided similar results in most instances. However, the external validity of assessing change was poor in the PROMIS PF and UE as well as some follow-up time points of the PROMIS PI and qDASH when mean scores were compared in the subsamples with no-change in condition versus meaningful change.

We tested a traditional time-frame for three-month and six-month follow-up capturing a window of 10 days on either side of the follow-up cut-off. Strict cut-off limits restrict the inclusion of patient scores for those who did not have follow-up visits that fit within the narrow time-frames. The relevance of the sampling cut-offs to the interpretation can be seen with the small sample size (18--20 participants) in the 6-month follow-up group (170--190 days). This restricted sample was the only time-point that resulted in a 95% CI around the effect size that ranged low enough to include potential for a small effect in the interpretation. In contrast, the larger sample sizes in the other follow-up periods resulted in CI's with medium/large to large effects. We also tested 90 days and beyond and 180 days and beyond as alternative time-frames to test the robustness of these cut-offs to the measure's responsiveness. Our study findings that comparable effect sizes could be seen across the differing follow-up cut-offs, with minimal exceptions, provides cross-validation for the use of commonly used three and six-month follow-up cut-off points.

It is interesting to note that the time-period in which change scores were the greatest differed for different instruments. For the PROMIS PF, there was little difference between change scores at 3 and 6 month follow-up. For the PROMIS PI, pain interference change was greater at the earlier follow-up points. The PROMIS UE and qDASH similarly showed more change in function at earlier time points. These differences likely represent the greater heterogeneity in patient condition and treatment factors that occur by later measurement periods, but may also reflect the nature of improvement in upper extremity disorders. It may also reflect the low level of functioning and high levels of pain reported by this sample of upper extremity patients at baseline visits.

Prior work on the measurement characteristics of the PROMIS UE, PF, and PI CAT in a hand and upper extremity patient population have demonstrated the validity of these measures while minimizing respondent burden \[[@CR8], [@CR29]--[@CR32]\]. Whether or not these PROMIS instruments are able to detect patient reported change in health or function, however, has remained an important albeit open question. This study demonstrates the responsiveness of these three PROMIS instruments. Understanding responsiveness to change is essential in translational research to advance clinical trials, comparative effectiveness studies and most importantly, clinicians' knowledge in interpreting outcome measures enabling more meaningful interactions with patients.

Limitations {#Sec12}
-----------

All patients visiting the hand and upper extremity orthopaedic clinic were included in the assessment of responsiveness, and we did not characterize our results based on individual diagnosis or treatments. Differing disease conditions and/or treatments may show different responsiveness indices, and therefore the findings of this study should be considered preliminary. Future work may include investigation of the responsiveness of the PROMIS instruments for individual conditions and treatments. The sample size for the 6-month follow-up was small and results from this time-point may not be as reliable as those with larger samples. We are continuing to collect data from patients and will conduct further study with larger samples and different time frames as data become available. Future work should be performed to analyze upper extremity conditions at varying levels of function, not just change, to see if instruments are as responsive to those with high functioning as to those with lower levels of function. It would also be useful to consider the differences by anchor score, of those reporting varying levels of improvement. The PROMIS PF has been shown to have a ceiling effect especially in relation to items that fall in the upper extremity areas of function. \[[@CR29], [@CR33]\] In this patient population, functioning levels were low, so the ceiling effect likely did not impact the results. Both the PROMIS PF and PROMIS UE would benefit from this additional analysis of responsiveness at the upper levels of function in future research, potentially using Rasch modeling based on the distribution of scores rather than the external anchoring.

Conclusions {#Sec13}
===========

The PROMIS UE CAT, PF CAT, PI CAT, and qDASH were able to effectively detect change in physical function and pain interference in an orthopaedic hand and upper extremity clinic. The responsiveness of the PROMIS instruments demonstrated by this study adds to the prior rigorous psychometric validation of instruments reported in the literature, and should assist clinicians and researchers to make informed decisions regarding instrument selection in assessing patient reported outcomes in the upper extremity \[[@CR34]\].

Appendix {#Sec14}
========

Table 5PROMIS v1.2 Physical Function item bankItemIDQuestions1PFA10Are you able to stand for one hour?^a^2PFA11Are you able to do chores such as vacuuming or yard work?3PFA12Are you able to push open a heavy door?4PFA13Are you able to exercise for an hour?5PFA14r1Are you able to carry a heavy object (over 10 pounds/ 5 kg)?6PFA15Are you able to stand up from an armless straight chair?7PFA16r1Are you able to dress yourself, including tying shoelaces and buttoning up your clothes?8PFA17Are you able to reach into a high cupboard?9PFA18Are you able to use a hammer to pound a nail?10PFA19r1Are you able to run or jog for two miles (3 km)?11PFA20Are you able to cut your food using eating utensils?12PFA21Are you able to go up and down stairs at a normal pace?13PFA22Are you able to open previously opened jars?14PFA23Are you able to go for a walk of at least 15 min?15PFA25Are you able to do yard work like raking leaves, weeding, or pushing a lawn mower?16PFA28Are you able to open a can with a hand can opener?17PFA29r1Are you able to pull heavy objects (10 pounds/5 kg) towards yourself?18PFA30Are you able to step up and down curbs?19PFA31r1Are you able to get up from the floor from lying on your back without help?20PFA32Are you able to stand with your knees straight?21PFA33Are you able to exercise hard for half an hour?22PFA34Are you able to wash your back?23PFA35Are you able to open and close a zipper?24PFA36Are you able to put on and take off a coat or jacket?25PFA37Are you able to stand for short periods of time?26PFA38Are you able to dry your back with a towel?27PFA39r1Are you able to run at a fast pace for two miles (3 km)?28PFA40Are you able to turn a key in a lock?29PFA41Are you able to squat and get up?30PFA42Are you able to carry a laundry basket up a flight of stairs?31PFA43Are you able to write with a pen or pencil?32PFA44Are you able to put on a shirt or blouse?33PFA45Are you able to get out of bed into a chair?34PFA47Are you able to pull on trousers?35PFA48Are you able to peel fruit?36PFA49Are you able to bend or twist your back?37PFA50Are you able to brush your teeth?38PFA51Are you able to sit on the edge of a bed?39PFA52Are you able to tie your shoelaces?40PFA53Are you able to run errands and shop?41PFA54Are you able to button your shirt?42PFA55Are you able to wash and dry your body?43PFA56Are you able to get in and out of a car?44PFA8Are you able to move a chair from one room to another?45PFA9Are you able to bend down and pick up clothing from the floor?46PFB10Are you able to climb up five steps?47PFB11Are you able to wash dishes, pots, and utensils by hand while standing at a sink?48PFB12Are you able to make a bed, including spreading and tucking in bed sheets?49PFB13Are you able to carry a shopping bag or briefcase?50PFB14Are you able to take a tub bath?51PFB15Are you able to change the bulb in a table lamp?52PFB16Are you able to press with your index finger (for example ringing a doorbell)?53PFB17Are you able to put on and take off your socks?54PFB18Are you able to shave your face or apply makeup?55PFB19Are you able to squeeze a new tube of toothpaste?56PFB20Are you able to cut a piece of paper with scissors?57PFB21Are you able to pick up coins from a table top?58PFB22Are you able to hold a plate full of food?59PFB23Are you able to pour liquid from a bottle into a glass?60PFB24Are you able to run a short distance, such as to catch a bus?61PFB25Are you able to push open a door after turning the knob?62PFB26Are you able to shampoo your hair?63PFB27Are you able to tie a knot or a bow?64PFB28r1Are you able to lift 10 pounds (5 kg) above your shoulder?65PFB29Are you able to lift a full cup or glass to your mouth?66PFB30Are you able to open a new milk carton?67PFB31Are you able to open car doors?68PFB32Are you able to stand unsupported for 10 min?69PFB33Are you able to remove something from your back pocket?70PFB34Are you able to change a light bulb overhead?71PFB36Are you able to put on a pullover sweater?72PFB37Are you able to turn faucets on and off?73PFB39r1Are you able to reach and get down a 5 pound (2 kg) object from above your head?74PFB40Are you able to stand up on tiptoes?75PFB41Are you able to trim your fingernails?76PFB42Are you able to stand unsupported for 30 min?77PFB56r1Are you able to lift one pound (0.5 kg) to shoulder level without bending your elbow?78PFB8r1Are you able to carry two bags filled with groceries 100 yards (100 m)?79PFB9Are you able to jump up and down?80PFC13r1Are you able to run 100 yards (100 m)?81PFC29Are you able to walk up and down two steps?82PFC31Are you able to reach into a low cupboard?83PFC32Are you able to climb up 5 flights of stairs?84PFC33r1Are you able to run ten miles (16 km)?85PFC38Are you able to walk at a normal speed?86PFC39Are you able to stand without losing your balance for several minutes?87PFC40Are you able to kneel on the floor?88PFC41Are you able to sit down in and stand up from a low, soft couch?89PFC43Are you able to use your hands, such as for turning faucets, using kitchen gadgets, or sewing?90PFC45r1Are you able to sit on and get up from the toilet?91PFC46Are you able to transfer from a bed to a chair and back?92PFC47Are you able to be out of bed most of the day?93PFC49Are you able to water a house plant?94PFC51Are you able to wipe yourself after using the toilet?95PFC52Are you able to turn from side to side in bed?96PFC53Are you able to get in and out of bed?97PFC6r1Are you able to walk a block (100 m) on flat ground?98PFC7r1Are you able to run five miles (8 km)?99PFA1Does your health now limit you in doing vigorous activities, such as running, lifting heavy objects, participating in strenuous sports?^b^100PFA3Does your health now limit you in bending, kneeling, or stooping?101PFA4Does your health now limit you in doing heavy work around the house like scrubbing floors, or lifting or moving heavy furniture?102PFA5Does your health now limit you in lifting or carrying groceries?103PFA6Does your health now limit you in bathing or dressing yourself?104PFB1Does your health now limit you in doing moderate work around the house like vacuuming, sweeping floors or carrying in groceries?105PFB3Does your health now limit you in putting a trash bag outside?106PFB43Does your health now limit you in taking care of your personal needs (dress, comb hair, toilet, eat, bathe)?107PFB44Does your health now limit you in doing moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf?108PFB48Does your health now limit you in taking a shower?109PFB49Does your health now limit you in going for a short walk (less than 15 min)?110PFB5r1Does your health now limit you in hiking a couple of miles (3 km) on uneven surfaces, including hills?111PFB51Does your health now limit you in participating in active sports such as swimming, tennis, or basketball?112PFB54Does your health now limit you in going OUTSIDE the home, for example to shop or visit a doctor's office?113PFB7Does your health now limit you in doing strenuous activities such as backpacking, skiing, playing tennis, bicycling or jogging?114PFC10Does your health now limit you in climbing several flights of stairs?115PFC12Does your health now limit you in doing two hours of physical labor?116PFC35Does your health now limit you in doing eight hours of physical labor?117PFC36r1Does your health now limit you in walking more than a mile (1.6 km)?118PFC37Does your health now limit you in climbing one flight of stairs?119PFC54Does your health now limit you in getting in and out of the bathtub?120PFC56Does your health now limit you in walking about the house?121PFB50How much difficulty do you have doing your daily physical activities, because of your health?^ca^Response options for questions 1--98 are 1 = Unable to do; 2 = With much difficulty; 3 = With some difficulty; 4 = With a little difficulty; 5 = Without any difficulty^b^Response options for questions 99--123 are 1 = Cannot do; 2 = Quite a lot; 3 = Somewhat; 4 = Very little; 5 = Not at all^c^Response options for question 121 are 1 = Can't do because of health, 2 = A lot of difficulty; 3 = Some difficulty; 4 = A little bit of difficulty; 5 = No difficulty at all

Table 6PROMIS v1.2 Upper Extremity item bankItemIDQuestion1PFA16r1Are you able to dress yourself, including tying shoelaces and buttoning your clothes?2PFA17Are you able to reach into a high cupboard?3PFA18Are you able to use a hammer to pound a nail?4PFA20Are you able to cut your food using eating utensils?5PFA28Are you able to open a can with a hand can opener?6PFA29r1Are you able to pull heavy objects (10 pounds/5 kg) towards yourself?7PFA35Are you able to open and close a zipper?8PFA38Are you able to dry your back with a towel?9PFA44Are you able to put on a shirt or blouse?10PFA48Are you able to peel fruit?11PFA54Are you able to button your shirt?12PFB21Are you able to pick up coins from a table top?13PFB22Are you able to hold a plate full of food?14PFB30Are you able to open a new milk carton?15PFB33Are you able to remove something from your back pocket?16PFB36Are you able to put on a pullover sweater?Response options for questions 1--16 are 1 = Unable to do; 2 = With much difficulty; 3 = With some difficulty; 4 = With a little difficulty; or 5 = Without any difficulty

Table 7PROMIS v1.1 Pain Interference item bankItemIDQuestion1PAININ1In the past 7 days, how difficult was it for you to take in new information because of pain?^a^2PAININ3In the past 7 days, how much did pain interfere with your enjoyment of life?^a^3PAININ5In the past 7 days, how much did pain interfere with your ability to participate in leisure activities?^a^4PAININ6In the past 7 days, how much did pain interfere with your close personal relationships?^a^5PAININ8In the past 7 days, how much did pain interfere with your ability to concentrate?^a^6PAININ9In the past 7 days, how much did pain interfere with your day to day activities?^a^7PAININ10In the past 7 days, how much did pain interfere with your enjoyment of recreational activities?^a^8PAININ11In the past 7 days, how often did you feel emotionally tense because of your pain?^a^9PAININ12In the past 7 days, how much did pain interfere with the things you usually do for fun?^a^10PAININ13In the past 7 days, how much did pain interfere with your family life?^a^11PAININ17In the past 7 days, how much did pain interfere with your relationships with other people?^a^12PAININ18In the past 7 days, how much did pain interfere with your ability to work (included work at home)?^a^13PAININ19In the past 7 days, how much did pain make it difficult to fall asleep?^a^14PAININ20In the past 7 days, how much did pain feel like a burden to you?^a^15PAININ22In the past 7 days, how much did pain interfere with work around the home?^a^16PAININ31In the past 7 days, how much did pain interfere with your ability to participate in social activities? ^a^17PAININ34In the past 7 days, how much did pain interfere with your household chores? ^a^18PAININ35In the past 7 days, how much did pain interfere with your ability to make trips from home that kept you gone for more than 2 h? ^a^19PAININ36In the past 7 days, how much did pain interfere with your enjoyment of social activities? ^a^20PAININ48In the past 7 days, how much did pain interfere with your ability to do household chores? ^a^21PAININ49In the past 7 days, how much did pain interfere with your ability to remember things? ^a^22PAININ56In the past 7 days, how irritable did you feel because of pain? ^a^23PAININ14In the past 7 days, how much did pain interfere with doing your tasks away from home (e.g., getting groceries, running errands)? ^a^24PAININ16In the past 7 days, how often did pain make you feel depressed?^b^25PAININ24In the past 7 days, how often was pain distressing to you? ^b^26PAININ26In the past 7 days, how often did pain keep you from socializing with others?^b^27PAININ29In the past 7 days, how often was your pain so severe you could think of nothing else? ^b^28PAININ32In the past 7 days, how often did pain make you feel discouraged?^b^29PAININ37In the past 7 days, how often did pain make you feel anxious?^b^30PAININ38In the past 7 days, how often did you avoid social activities because it might make you hurt more?^b^31PAININ40In the past 7 days, how often did pain prevent you from walking more than 1 mile?32PAININ42In the past 7 days, how often did pain prevent you from standing for more than one hour?^b^33PAININ46In the past 7 days, how often did pain make it difficult for you to plan social activities? ^b^34PAININ47In the past 7 days, how often did pain prevent you from standing for more than 30 min?^b^35PAININ50In the past 7 days, how often did pain prevent you from sitting for more than 30 min?^b^36PAININ51In the past 7 days, how often did pain prevent you from sitting for more than 10 min?^b^37PAININ52In the past 7 days, how often was it hard to plan social activities because you didn't know if you would be in pain?^b^38PAININ53In the past 7 days, how often did pain restrict your social life to your home?^b^39PAININ55In the past 7 days, how often did pain prevent you from sitting for more than one hour? ^b^40PAININ54In the past 7 days, how often did pain keep you from getting into a standing position?^ba^Response options for questions 1--23 are 1 = Not at all; 2 = A little bit; 3 = Somewhat; 4 = Quite a bit; 5 = Very Much^b^Response options for questions 24--40 are 1 = Never; 2 = Rarely; 3 = Sometimes; 4 = Often; 5 = Always

Table 8qDASH item bankItemQuestion*Please rate your ability to do the following activities in the last week.*1Open a tight or new jar.^a^2Do heavy household chores (e.g., wash walls, floors).^a^3Carry a shopping bag or briefcase.^a^4Wash your back.^a^5Use a knife to cut food.^a^6Recreational activities in which you take some force or impact through your arm, shoulder or hand (e.g., golf, hammering, tennis, etc.).^a^7During the past week, to what extent has your arm, shoulder or hand problem interfered with your normal social activities with family, friends, neighbors or groups?^b^8During the past week, were you limited in your work or other regular daily activities as a result of your arm, shoulder or hand problem?^c^*Please rate the severity of the following symptoms in the last week.*9Arm, shoulder or hand pain.^d^10Tingling (pins and needles) in your arm, shoulder or hand.^d^11During the past week, how much difficulty have you had sleeping because of the pain in your arm, shoulder or hand?^aa^Response options for questions 1--6, 11 are 1 = No difficulty; 2 = Mild difficulty; 3 = Moderate difficulty; 4 = Severe difficulty; 5 = So much difficulty that I can't sleep^b^Response options for question 7 are 1 = Not at all; 2 = Slightly; 3 = Moderately; 4 = Quite a bit; 5 = Extremely^c^Response options for question 8 are 1 = Not limited at all; 2 = Slightly limited; 3 = Moderately limited; 4 = Very limited; 5 = Unable^d^Response options for questions 9--10 are 1 = None; 2 = Mild; 3 = Moderate; 4 = Severe; 5 = Extreme

ES

:   Effect size

PF CAT

:   PROMIS Physical Function computerized adaptive test

PI CAT

:   PROMIS Pain Interference computerized adaptive test

PRO

:   Patient-reported outcome

PROMIS

:   Patient Reported Outcomes Measurement Information System

qDASH

:   Disabilities of the Arm, Shoulder, and Hand; shortened version

SRM

:   Standardized response mean

UE CAT

:   PROMIS Upper Extremity computerized adaptive test
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